Lung-cancer reduction from smoking cessation and radon remediation: A preliminary cost-analysis in Northamptonshire, UK

Environment International

Volumn 37, Issue 2, 2011, Pages 375-382

  Groves Kirkby, C J ^a,b   Timson, K ^a   Shield, G ^c   Denman, A R ^a,b   Rogers, S ^a   Phillips, P S ^b  

^a NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NORTHAMPTON   (United Kingdom)

^c Public Health Department   (United Kingdom)

Author keywords

Cost effectiveness; Radon remediation; Smoking cessation

Indexed keywords

BIOLOGICAL ORGANS; COST EFFECTIVENESS; COST REDUCTION; COSTS; DISEASES; ENVIRONMENTAL MANAGEMENT; HEALTH; HEALTH RISKS; POLLUTION; RADON; REMEDIATION; RISK ASSESSMENT;

COST EFFECTIVE; HEALTH BENEFITS; HEALTH IMPROVEMENTS; QUANTITATIVE ASSESSMENTS; RADON EXPOSURE; RISK REDUCTIONS; SMOKING CESSATIONS; UNITED KINGDOM;

COST BENEFIT ANALYSIS;

RADON; TOBACCO SMOKE;

CANCER; COST-BENEFIT ANALYSIS; HEALTH RISK; RADON; REMEDIATION; RISK FACTOR; SMOKING;

AGED; ARTICLE; BIOREMEDIATION; CANCER CONTROL; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECOSYSTEM RESTORATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH PROMOTION; HOUSEHOLD; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; UNITED KINGDOM;

ENGLAND; NORTHAMPTONSHIRE; UNITED KINGDOM;

EID: 78751631880     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2010.10.010     Document Type: Article

References (42)

1. BEIR VI (Committee on Health Risks of Exposure to Radon) Health risks of exposure to radon 1999, National Academy Press, Washington DC.
2. Briggs D.J., Denman A.R., Gulliver J., Marley R.F., Kennedy C.A., Phillips P.S., et al. Time-activity modelling of domestic exposures to radon. J Environ Manage 2003, 67:107-120.
3. Coskeran T., Denman A.R., Phillips P.S. The costs of radon mitigation in domestic properties. Health Policy 2001, 57:97-109.
4. Coskeran T., Denman A.R., Phillips P.S., Gillmore G.K. A critical comparison of domestic radon remediation programmes in five areas of England. J Environ Radioact 2002, 62:129-144.
5. Coskeran T., Denman A.R., Phillips P.S., Tornberg R. A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK. Health Policy 2005, 71:43-56.
6. Coskeran T., Denman A., Phillips P., Gillmore G., Tornberg R. A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within Primary Care Trusts in Central England. Sci Total Environ 2006, 366:32-46.
7. Darby S., Whitley E., Silcocks P., Thackrar B., Green M., Lomas P.R., et al. Risk of lung-cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer 1998, 78:394-408.
8. Darby S., Hill D.C., Doll R. Radon-a likely carcinogen at all exposures. Ann Oncol 2001, 12:1341-1351.
9. Darby S., Hill D.C., Auvinen A., Barros-Dios J.M., Baysson H., Bochicchio F., et al. Radon in homes and risk of lung-cancer: collaborative analysis of individual data from 13 European case-control studies. Br Med J 2005, 330:223-228.
10. DEFRA Radon: good practice guide 2003, DEFRA, London.
11. Degrange J.P., Birchall A., Haylock R., Janssens A., Levy F.P., Marsh J., Muirhead C.A. European Commission software tool for radon risk calculation and evaluation of countermeasures. Proc. 10th International Congress of the International Radiation Protection Association, Hiroshima Japan 2000.
12. Denman A.R., Barker S.P., Parkinson S., Phillips P.S. The health benefits and cost effectiveness of the radon mitigation programme in NHS properties in Northamptonshire. J Radiol Prot 1997, 17:253-259.
13. Denman A.R., Phillips P.S. The cost-effectiveness of radon mitigation in schools in Northamptonshire. J Radiol Prot 1998, 18:203-208.
14. Denman A.R., Phillips P.S. Workplace radon in Northamptonshire. Environ Manage Health 1998, 9:194-199.
15. Denman A.R., Phillips P.S. A review of the cost-effectiveness of radon mitigation in domestic properties in Northamptonshire. J Radiol Prot 1998, 18:119-124.
16. Denman A.R., Phillips P.S., Tornberg R. A comparison of the costs and benefits of radon remediation programmes in new and existing houses in Northamptonshire. J Environ Manage 2000, 59:21-30.
17. Denman A.R., Groves-Kirkby C.J., Phillips P.S., Tornberg R. Using the European Commission Radon Software to estimate the individual health benefits of a domestic radon remediation programme. J Radiol Prot 2004, 24:83-89.
18. Denman A.R., Phillips P.S., Tornberg R., Groves-Kirkby C.J. Analysis of the individual health benefits accruing from a domestic radon remediation programme. J Environ Radioact 2005, 79:7-23.
19. Denman A.R., Timson K., Shield G., Groves-Kirkby C.J., Rogers S., Campbell J., et al. Local health campaigns to reduce lung cancers induced by radon and smoking-who responds?. Health Policy 2009, 93:201-206.
20. Dept.of Health Statistics on smoking: England 2003, November 2003. London.
21. Dept.of Health Commissioning a patient-led NHS 2005, London.
22. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50years observations on male British doctors. Br Med J 2004, 328:1519-1527.
23. Godfrey C., Parrott S., Coleman T., Pound E.R. The cost-effectiveness of the English smoking treatment services: evidence from practice. Addiction 2005, 100(Suppl. 2):70-83.
24. Gray A., Read S., McGale P., Darby S. Lung-cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. Br Med J 2009, 338:a3110.
25. Green B.M.R., Miles J.C.H., Bradley E.J., Rees D.M. Radon Atlas of England and Wales. NRPB-W26 2002, National Radiological Protection Board, Didcot.
26. Groves-Kirkby C.J., Denman A.R., Timson K., Shield G., Phillips P.S., Rogers S. Radon, tobacco and lung-cancer-the significance of smoking cessation programmes. Health Prot Matters 2008, 12:40-44.
27. Gunby J., Darby S., Miles J., Green B., Cox D. Factors affecting indoor radon concentrations in the United Kingdom. Health Phys 1993, 64:2-12.
28. HM Government Smoking kills: a white paper on tobacco, CM4177 1998, The Stationery Office, London.
29. Kennedy C.A., Gray A.M., Denman A.R., Phillips P.S. A cost effectiveness analysis of a residential radon remediation programme in the United Kingdom. Br J Cancer 1999, 81:1243-1247.
30. Krewski D., Lubin J., Zielinski J.M., Alavanja M., Catalan V.S., Field R.W., et al. Residential radon and risk of lung-cancer: a combined analysis of 7 North American case-control studies. Epidemiology 2005, 16:137-145.
31. Lubin J.H., Boice J.D. Lung-cancer risk from residential radon: meta-analysis of eight epidemiological studies. J Natl Cancer Inst 1997, 89:49-57.
32. Miles J.C.H., Green B.M.R., Lomas P.R. Radon affected areas: Derbyshire, Northamptonshire and Somerset. Docs NRPB 1992, 3:19-28.
33. National Institute for Health and Clinical Excellence (NIHCE) Guide to the methods of technology appraisal 2008, National Institute for Health and Clinical Excellence, London.
34. Netten A. Unit costs of health and social care 2000 2000, Personal Social Services Research Unit, University of Kent, Canterbury.
35. Office of National Statistics Northamptonshire population pyramid http://www.statistics.gov.uk/census2001/pyramids/pages/34.asp.
36. O'Riordan M. Human exposure to radon in homes: recommendations for the practical application of the Board's statement. Docs NRPB 1990, 1:17-32.
37. Parrott S., Godfrey C. ABC of smoking cessation. Br Med J 2007, 328:947.
38. Parrott S., Godfrey C., Raw M., West R., McNeill A. Guidance for commissioners on the cost-effectiveness of smoking cessation interventions. Thorax 1998, 53(Suppl. 5, Pt. 2):S2-S38.
39. Phillips P.S., Fraser J.D., Denman A.R. Effectiveness of secondary radon protection in Northamptonshire houses. Environ Manage Health 2000, 11:337-352.
40. Ronckers E.T., Groot W., Ament A.J.H.A. Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectiveness. Med Decis Mak 2005, 25:437-448.
41. Stapleton J. Cost effectiveness of NHS smoking cessation services On-line at. http://www.ash.org.uk/files/documents/ASH_427.pdf.
42. Woolacott N.F., Jones L., Forbes C.A., Mather L.C., Sowden A.J., Song F.J., et al. The clinical effectiveness and cost-effectiveness of Bupropion and Nicotine Replacement Therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002, 6:16.